Biotronik SE had one patents in big data during Q1 2024.The patent describes a method for supporting a patient’s cardiac health control using a remote device with a processor and memory. It involves correcting physiological data values using a pre-defined correction factor determined by an AI algorithm. The remote server analyzes the relationships among physiological data to provide a more accurate picture of the patient’s health condition, reducing information overload. GlobalData’s report on Biotronik SE gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Biotronik SE had no grants in big data as a theme in Q1 2024.
Recent Patents
Application: Method for supporting a patient's health control and respective system (Patent ID: US20240013910A1)
The patent filed by Biotronik SE & Co KG describes a method for supporting a patient's cardiac health control using a remote device connected to an implanted medical device. The method involves receiving physiological data sets, assessing them against reference ranges, correcting data values based on pre-defined correction factors determined by an AI algorithm, and storing the corrected data. The AI algorithm helps reduce information overload and provides a more accurate picture of the patient's health condition. The method also includes trend assessment using AI algorithms to determine score values and labels associated with specific time periods, allowing for more precise monitoring and analysis of the patient's health status.
Furthermore, the patent includes claims detailing the use of linear regression or deep learning algorithms for correction factor determination, patient-specific or general correction factors, training the AI algorithm with patient data for personalized results, and displaying corrected data on remote device screens. The system also involves comparing score values with thresholds and providing alerts if values deviate. Overall, the patent outlines a comprehensive method and system for remote monitoring and support of a patient's cardiac health, leveraging AI algorithms for data analysis and correction to enhance the accuracy and efficiency of health control measures.
To know more about GlobalData’s detailed insights on Biotronik SE, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.